{
  "docId": "019dd923-622c-750b-8b9a-4b91788fc785",
  "docSlug": "5fadb686cc03",
  "documentTitle": "Twist Bioscience (TWST)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2022-11-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 189,
  "pageCount": 236,
  "prevPage": 188,
  "nextPage": 190,
  "slideType": "quote_slide",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses bolding and highlighting to emphasize negative sentiment regarding Twist's market position.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-4b91788fc785/189",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785#slide-189",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Twist isn’t taking market share from their key, low-priced Asian competitor",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0933-75bb-9bf3-b266a6f47b6e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Twist hasn’t had “much of an impact” on the market and key competitors like Genscript; don’t see them as threat anymore or as a “major competitor”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "443fb5f2-67c2-4ef8-bcb5-2f5268259657",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Twist is offering legacy products Asian competitors have long provided; cheaper and faster to order from Asia",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5dafd222-9f81-4ec0-baed-c0b2c8698ded",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Twist isn’t taking market share from their key, low-priced Asian competitor",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f17ca6c-f194-48ae-b8ec-e0b526c0411f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.31
      },
      "kind": "quote",
      "text": "“To be brutally honest, they really didn’t have much impact as we thought they would [when they launched]...they really didn’t have much impact on us, and our business continued to grow, like 20% to 30% every year...we haven’t seen them as a big threat...I don’t see them as a major competitor to us. –Executive at Genscript, key Twist competitor",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c60c94a-f3fe-4290-91ac-240238be73bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.52
      },
      "kind": "quote",
      "text": "“All of those services we already have at GenScript, and we have been doing it for over 20 years now...people can find a lot more affordable and quicker solutions outside of the country.” –Executive at Genscript, key Twist competitor",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0500057-8937-4eae-911e-c10b7712bdb1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.69
      },
      "kind": "quote",
      "text": "Q: “When you say they haven’t made an impact in the market, you’re talking about their antibody discovery effort?” A: “Yes, usually antibody discovery, but even in gene synthesis, just looking at our numbers, it has been going up steadily, and then there’s no basis for us to say that Twist is taking a lot of our clients...there is no basis for me to say that they are taking market share from us.” –Executive at Genscript, key Twist competitor",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f22a0e86-9d87-4a13-a73a-ed095a378623",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“To be brutally honest, they really didn't have much impact as we thought they would [when they launched]...they really didn't have much impact on us, and our business continued to grow, like 20% to 30% every year, which is beating the market in general on average, and we are still a market leader. So, we haven't really seen them as a big threat as we thought they would be...we haven't seen much of an impact, and we don't see them as a major threat for business anymore.” — Executive at Genscript, key Twist competitor",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0933-75bb-9bf3-b4993de67e78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59c774e5-0a93-4488-b1d1-33f928c2fe06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "An executive at Genscript - Twist’s key Chinese competitor - provided similar market intelligence, stating that Twist hasn’t had “much of an impact” on the market or companies like Genscript. He stated that they no longer see Twist as a threat nor even as a “major competitor.” He called out their nascent, much-hyped antibody discovery business as a flop: “no basis to say they are taking market share from us.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2666e6c-3dd0-4a12-8ff8-306f4a1a6234",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}